Host Cell Line Engineering
Host Cell Line Engineering is the systematic modification of a host cell line's genetic and physiological properties to enhance its capacity for the efficient and scalable production of recombinant proteins, distinguishing it from other protein expression strategies by its focus on host-level optimization rather than vector or process-level improvements.
94
Publications
4.8K
Citations
562
Authors
159
Institutions
Publications per year
2017–2026
22
94
Naoko Yamane‐Ohnuki, Satoko Kinoshita, Miho Inoue‐Urakubo et al. · Biotechnology and Bioengineering · 2004 · 574 citations
Pharmacy, Biochemistry, Immunology +16
M Haraguchi, S. Yamashiro, Akira Yamamoto et al. · Proceedings of the National Academy of Sciences · 1994 · 212 citations
1–5 of 94
562
3
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 562
159
Biotechnology Institute
Washington D.C., United States
4 h-index
12 publications
448 citations

Johns Hopkins University
Baltimore, United States
4 h-index
7 publications
270 citations
BOKU University
Vienna, Austria
4 h-index
17 publications
1.1K citations
Bioprocessing Technology Institute
Singapore, Singapore
4 h-index
38 publications
2.9K citations
Agency for Science, Technology and Research
Singapore, Singapore
4 h-index
48 publications
3.7K citations
Helmholtz Centre for Infection Research
Braunschweig, Germany
3 h-index
10 publications
570 citations
Lonza (United Kingdom)
Slough, United Kingdom
3 h-index
6 publications
236 citations
Pfizer (United States)
New York, United States
3 h-index
11 publications
758 citations
1–8 of 159
16 publications · 1.3K citations
15
h-index
12 publications · 587 citations
12
h-index
4 publications · 203 citations
4
h-index
4 publications · 208 citations
4
h-index
Book series · 3 publications · 82 citations
3
h-index
1–5